Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 19 (3) , 226-230
Abstract
Prevalence of obstetric complications in women with deficiency of natural anticoagulants is difficult, because these defects are very rare in general population. Furthermore, the available data on prophylactic intervention in such individuals to decrease the obstetric risk are also very limited. To evaluate in a setting of women with rare hereditary thrombophilias, deficiency of antithrombin, protein C or protein S whether thromboprophylaxis during pregnancy could affect foeto-maternal outcome. Retrospective cohort study in two Italian thrombosis centres: 32 women with an established hereditary deficiency of natural anticoagulants antithrombin, protein C or protein S were enrolled because of a history of unexplained foetal losses with or without venous thromboembolism. Overall, information on the management of 103 pregnancies was obtained and the outcome in the absence or in the presence of enoxaparin treatment was recorded. Live births were recorded in 18 women (56.2%). Ten women had early foetal losses, 16 intrauterine foetal death and six both. Eight pregnancies were treated with enoxaparin. Seven out of eight treated pregnancies [87.5%, 95% confidence interval (CI) 52.9–97.7] and 27 out of 95 not-treated pregnancies (28.4%, 95% CI 20.3–38.1) resulted in the delivery of a live newborn (Fisher exact test: P = 0.002), with a risk of foetal loss in untreated pregnancies 3.1 times (95% CI 1.7–3.5) higher than in treated ones. In this setting of patients with rare causes of thrombophilia, antithrombotic prophylaxis during pregnancy improves foeto-maternal outcome.Keywords
This publication has 30 references indexed in Scilit:
- A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2005
- Molecular diversity and thrombotic risk in protein S deficiency: The PROSIT studyHuman Mutation, 2005
- Genetic Thrombophilias and Preeclampsia: A Meta-AnalysisObstetrics & Gynecology, 2005
- Inherited thrombophilia and life‐time risk of venous thromboembolism: is the burden reducible?Journal of Thrombosis and Haemostasis, 2004
- The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general populationBritish Journal of Haematology, 2004
- Evaluation of the Association Between Hereditary Thrombophilias and Recurrent Pregnancy LossArchives of internal medicine (1960), 2004
- Association of Leiden mutation in Factor V gene with hypertension in pregnancy and pre-eclampsiaJournal Of Hypertension, 2003
- Prothrombotic Genotypes Are not Associated with Pre-eclampsia and Gestational Hypertension: Results from a Large Population-based Study and Systematic ReviewThrombosis and Haemostasis, 2002
- Prevalence of antithrombin deficiency in the healthy populationBritish Journal of Haematology, 1994
- Thrombosis in Antithrombin-III-deficient PersonsAnnals of Internal Medicine, 1992